TLSA - Latest News
Tiziana Life Sciences Ltd (TLSA), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $75.1M. Beta to the broader market is 0.42.
The article list below shows the most recent TLSA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent TLSA Headlines
Qualcomm raises long-term targets as analysts highlight data center, edge AI opportunities
proactiveinvestors.com - Jun 25, 2026
Qualcomm Inc (NASDAQ:QCOM, XETRA:QCI) outlined higher long-term revenue and earnings targets at its investor day, prompting analysts at Bank of Americ
Tiziana Life Sciences doses last patient in Phase 2a multiple sclerosis trial
proactiveinvestors.com - Jun 25, 2026
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said the last patient in its Phase 2a clinical trial has received a first dose of intranasal foralumab for the
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
globenewswire.com - Jun 25, 2026
Top line data readout expected in late Q3/early Q4 INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase 2a trial using Intranasal F
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
globenewswire.com - Jun 15, 2026
BOSTON, June 15, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York
globenewswire.com - May 28, 2026
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidat
How News Affects TLSA Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track TLSA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked TLSA news questions
- What is the latest TLSA news headline?
- The most recent TLSA headline (Jun 25, 2026) is "Qualcomm raises long-term targets as analysts highlight data center, edge AI opportunities". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the TLSA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What TLSA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual TLSA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.